Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.43 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.43 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL84051 | 1.00 | SMN1; SMN2 (0.58) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| SCHEMBL29401687 | 1.00 | SMN1; SMN2 (0.58) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| SCHEMBL29424134 | 1.00 | SMN1; SMN2 (0.58) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| Methane SCHEMBL8775730 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| Bromide SCHEMBL22440321 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| SCHEMBL28480196 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| Hydrochloric Acid SCHEMBL18039122 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| Hydrochloric Acid SCHEMBL30785438 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| SCHEMBL28002956 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E | |
| SCHEMBL27951465 | 0.97 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1AHRTRPV4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7319099-B2 | Such as 1-{3-fluoro-4-[4-(2-isopropoxy-5-methanesulfonyl benzoyl)-piperazin-1-yl]-phenyl}-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease | HOFFMANN-LA ROCHE INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-20050209241-A1 | Benzoyl-piperazine derivatives | HOFFMANN-LA ROCHE INC. | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209241-A1 | Benzoyl-piperazine derivatives | SLC1A2, SLC18A2, SLC6A7 | SMN1; SMN2 1268/4885L3MBTL1 2359/4885AHR 1866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.